Other Content - BioPharm International

ADVERTISEMENT

Other Content

EMA Warns of Falsified Herceptin Vials

April 16, 2014

EMA notifies EU healthcare professionals of the falsified cancer drug Herceptin.

Mallinckrodt to Acquire Questcor Pharmaceuticals

April 16, 2014

Mallinckrodt will acquire Questcor to create a diversified, high-growth specialty pharmaceuticals company.

American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform

April 11, 2014

Biotechnology developer American CryoStem and Rutgers University partner on stem-cell platform technology development.

Center for Biologics Evaluation and Research Relocates

April 11, 2014

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.

PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth

April 11, 2014

A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.

FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines

April 10, 2014

FDA develops an assay that could speed the release of pandemic influenza vaccines.

Sun Pharma to Acquire Ranbaxy

April 7, 2014

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.

Merck Announes Management Changes

April 7, 2014

Merck promotes internal managers to head Merck Millipore and Consumer Health Divisions.

Baxter to Split Into Biopharmaceuticals and Medical Products Companies

March 27, 2014

Baxter announces plans to split into two independent companies by mid-2015.

ADVERTISEMENT

ADVERTISEMENT

Click here